Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy. - Wikidata - wikimedia - TriplyDB

Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy.

Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy.

http://www.wikidata.org/entity/Q38037048

about

Production and clinical development of nanoparticles for gene delivery Bench-to-bedside translation of magnetic nanoparticles Lipid nanoparticles as carriers for RNAi against viral infections: current status and future perspectives NANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer?Pigmy MicroRNA: surveillance cops in Therapies kingdom Drug delivery systems, CNS protection, and the blood brain barrier Mechanisms of nanoparticle-mediated siRNA transfection by melittin-derived peptides.Cationic lipid nanodisks as an siRNA delivery vehicle High-density lipoproteins for the systemic delivery of short interfering RNA.Toward Understanding Non-coding RNA Roles in Intracranial Aneurysms and Subarachnoid Hemorrhage Multifunctional core/shell nanoparticles cross-linked polyetherimide-folic acid as efficient Notch-1 siRNA carrier for targeted killing of breast cancer Design and evaluation of new pH-sensitive amphiphilic cationic lipids for siRNA delivery EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex.Cycloamylose-nanogel drug delivery system-mediated intratumor silencing of the vascular endothelial growth factor regulates neovascularization in tumor microenvironment Modified-chitosan/siRNA nanoparticles downregulate cellular CDX2 expression and cross the gastric mucus barrier.Highly effective antiangiogenesis via magnetic mesoporous silica-based siRNA vehicle targeting the VEGF gene for orthotopic ovarian cancer therapy Nanoporous silica-based protocells at multiple scales for designs of life and nanomedicine Reversal of multidrug resistance in MCF-7/Adr cells by codelivery of doxorubicin and BCL2 siRNA using a folic acid-conjugated polyethylenimine hydroxypropyl-β-cyclodextrin nanocarrier Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer.Phage display and targeting peptides: surface functionalization of nanocarriers for delivery of small non-coding RNAs.Evaluation of dendrimer type bio-reducible polymer as a siRNA delivery carrier for cancer therapy Ligand-targeted theranostic nanomedicines against cancer A glucose carbonate apatite complex exhibits in vitro and in vivo anti-tumour effects Melittin derived peptides for nanoparticle based siRNA transfection.Low-weight polyethylenimine cross-linked 2-hydroxypopyl-β-cyclodextrin and folic acid as an efficient and nontoxic siRNA carrier for gene silencing and tumor inhibition by VEGF siRNA.Cytotoxicity evaluation of carbon-encapsulated iron nanoparticles in melanoma cells and dermal fibroblasts.Recent advances in nanobiotechnology and high-throughput molecular techniques for systems biomedicine.Stimuli-responsive hybrid nanocarriers developed by controllable integration of hyperbranched PEI with mesoporous silica nanoparticles for sustained intracellular siRNA delivery.FGFR3 silencing by siRNA inhibits invasion of A549 cells Therapeutic nucleic acids: current clinical status.Delivery strategies and potential targets for siRNA in major cancer types S100A11 is a migration-related protein in laryngeal squamous cell carcinoma.Silencing the roadblocks to effective triple-negative breast cancer treatments by siRNA nanoparticles.Targeting cancer cell-specific RNA interference by siRNA delivery using a complex carrier of affibody-displaying bio-nanocapsules and liposomes.Molecular Mechanisms and Biological Functions of siRNA.Advances in Lipid Nanoparticles for siRNA Delivery.Molecular Crosstalking among Noncoding RNAs: A New Network Layer of Genome Regulation in Cancer.Selective targeting of point-mutated KRAS through artificial microRNAs.Multifunctionalization of graphene and graphene oxide for controlled release and targeted delivery of anticancer drugs.Overcoming cisplatin resistance in non-small cell lung cancer with Mad2 silencing siRNA delivered systemically using EGFR-targeted chitosan nanoparticles.

P2860

Q26752803-599E9895-EA2F-4158-B21C-6BCBBF67C6EB Q26850547-CA6EF8DB-34FA-476F-A8BC-394B30FDECBB Q26859021-6CFC8CB8-F06F-4964-A5D7-236274213B3B Q28078448-5796B945-A317-4618-927F-06E4FD92423F Q28818470-B202CFB3-8353-44B7-A1BC-59BF1819ABEB Q30432845-4CAF0EF9-D7F4-438F-B9ED-D4261BB98815 Q33581506-C5B5AAA5-9281-4C05-9457-5C9C8F3B0A45 Q33745473-DA1351C9-BC03-4358-B8B6-D1B26BE0B7A4 Q33786171-7112D79A-CE63-4DB8-ADF8-7A850AD0E34F Q33917323-67B8C940-8DAA-4AC9-B7E6-223BF109B7D7 Q34519604-0DF212DA-F2F9-42B3-B211-D58E843A2FB9 Q34782034-E7930331-F0E6-4FCB-AEC4-7D3D76C35C87 Q35018628-4373308A-016B-440A-BF35-788140FD5646 Q35052033-2C102146-56D7-428E-A197-B7A0B5F614DA Q35187370-5132F248-7A15-431C-A3ED-F46BE9D99150 Q35284618-0C1AD0D7-2E45-412F-AA76-AE70C9D00615 Q35334027-4F539D60-2F4C-4CF3-A7EE-9457D5078494 Q35546832-95E8E3C0-E663-40B6-A0F8-9553F24EDB2C Q35587385-A9A5F8F3-5E86-4DB1-AF41-559F477C7C7B Q35647485-519E5C9E-AE37-4391-8680-02148FBDA2DC Q35691030-A1FDA7C9-64FB-43FE-8BA5-116A836A69FE Q35895637-B7D21B12-EA0E-467D-B2D0-96DEED54C130 Q36288499-1A041F36-D7CD-4578-8C9B-868F8B5D744C Q36626455-B39C2062-5C94-4391-82E2-53B7E18FC848 Q36919338-19746A80-3CD0-4FE6-8410-BA3604EA4A27 Q37115126-56BBDBD3-1FE6-41DF-BB05-6627D00B61D0 Q37462618-92E9FCEB-120D-40B3-B6EE-6BDA1130A6C4 Q37500100-5BAA94E5-045A-4F5F-A4B4-E65939F43850 Q37582147-AA98A14A-D89A-4D2C-A986-E8269335879A Q38816703-977B529E-0679-4ACC-BB90-EEAB2F2B9CEB Q38853191-7CC71B8E-B88B-4CFE-827D-E4975B59ADE2 Q39094418-D8636D5C-9789-4C8D-81DD-E2256B743C34 Q39113994-53BCC604-9F64-4B34-A7DD-1B1D7D04B5F4 Q39135156-26DB8A5E-6772-4FA8-B9C3-D6AD53E5BA5E Q40077184-B576E7FC-6EF9-4049-9761-4EDBD123DD39 Q41786279-37EFF129-D7CD-4A5B-89C6-A7BEF3495E80 Q43878782-88A8FD85-42AD-469A-BFF8-E6B9BF02E2AD Q45058705-4E66BDCC-779E-47CF-9B3E-4C55CDD066F8 Q47745052-AC7D0CF4-000E-4F0B-9A66-785A98EACE59 Q48972059-B59DB571-A902-4EBE-BE72-D4D639804CC7

P2860

Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy.

http://www.wikidata.org/entity/Q38037048

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy.

@en

type

label

Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy.

@en

prefLabel

Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy.

@en

P1433

Q38037048-5276E12B-C4F6-47AD-A88A-F8DD1B0A6120

P1476

Q38037048-957031A8-D13C-45BA-BC32-3F8B8059AD00

P2093

Q38037048-1A16488B-260A-4DAF-9F3F-456FF20DA4DA

Q38037048-1F7C13FD-7BA7-4871-91BC-01928F36D4E4

Q38037048-4E536352-C7EC-4906-894C-A33EE0DB31B8

Q38037048-5F363BB6-A0AC-4F80-A7C0-893E3F5AD66D

Q38037048-C77330F9-8707-456D-B9F1-E74E49D6723D

P2860

Q38037048-014B865B-53D9-4BE8-8D93-7EA2B539AF90

Q38037048-01BD82F1-8779-42D8-BF5F-A6EEFD288BAA

Q38037048-022957CD-03BC-4CFE-AA3E-890F427B3FA7

Q38037048-03B42166-65A5-4625-9946-51EC0310DC3D

Q38037048-0412E949-242F-482E-9D37-29C718CB33D4

Q38037048-05E53113-8F41-4D5F-802A-386D62B6FF57

Q38037048-0872C1A7-F5BC-4A9B-BBEF-B84B4C458ABC

Q38037048-0A19929D-1551-48E8-8214-45058C0A9278

Q38037048-0C95B14E-96B6-4B96-B2C2-8FA3D11FD6E8

Q38037048-0ED71351-5D3D-466A-9230-37A0374FF20A

P304

Q38037048-8592C96C-75D7-4377-83EE-B935F95162AB

P31

Q38037048-3B660FBA-F2D3-4E10-BADF-1E3468FD0EEC

Q38037048-D4000BDD-5420-4308-8730-456EE72F82CB

P356

Q38037048-1E3BE721-6E0F-4AD3-B835-06D9B7B37BE7

P407

Q38037048-A48E574E-4CD1-45C8-9189-1249AE21BBF3

P478

Q38037048-DF8A0663-E59E-4C6C-866F-E26F2834544A

P50

Q38037048-89D63BD1-E874-4BBC-A179-B9D09DEE8AE7

Q38037048-8E6DB35D-E43D-444F-9FD3-2C5D48B39D7E

P577

Q38037048-5E3424DB-E66C-498E-B6D7-FE0BA67D8ECF

P5875

Q38037048-36D7661D-9FCA-454D-8D8C-E76A0AAEC91A

P698

Q38037048-43F85F9B-1B9B-432E-B88B-A2F02AD4AD30

P921

Q38037048-156453E8-A6D6-48BF-A942-E46196C99C10

Q38037048-3DF476FD-6A9F-4A53-A51B-3A8D8E6F04BC

Q38037048-AF48AA9B-A920-40E6-A439-7B2E3CAEE801

P932

Q38037048-239A3D7A-FA1D-41F7-81F6-3EB90F9151FC

P356

P1433

International Journal of Nanomedicine

P1476

Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy.

@en

P2093

Alberto Gulino

http://www.w3.org/2001/XMLSchema#string

Enzo Di Fabrizio

http://www.w3.org/2001/XMLSchema#string

Ermanno Miele

http://www.w3.org/2001/XMLSchema#string

Gian Paolo Spinelli

http://www.w3.org/2001/XMLSchema#string

Silverio Tomao

http://www.w3.org/2001/XMLSchema#string

P2860

Oxygen radical-mediated pulmonary toxicity induced by some cationic liposomes.

Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7

Quantum dots for live cells, in vivo imaging, and diagnostics

Small silencing RNAs: an expanding universe

The promises and pitfalls of RNA-interference-based therapeutics

Albumin-bound formulation of paclitaxel (Abraxane ABI-007) in the treatment of breast cancer

Quantum dots to monitor RNAi delivery and improve gene silencing

Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging

The response of mammalian cells to double-stranded RNA

siRNAs: potential therapeutic agents against hepatitis C virus

P304

3637-3657

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/IJN.S23696

http://www.w3.org/2001/XMLSchema#string

P407

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Elisabetta Ferretti

P577

2012-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230723324

http://www.w3.org/2001/XMLSchema#string

P698

22915840

http://www.w3.org/2001/XMLSchema#string

P921

manufactured product

P932

3418108

http://www.w3.org/2001/XMLSchema#string